 | • レポートコード：MRC2-11QY13668 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルツハイマーのグローバル市場について調査・分析したレポートです。種類別（コリン作動性、メマンチン、併用薬）市場規模、用途別（病院薬局、小売薬局、オンライン販売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルツハイマーの競争状況、市場シェア ・世界のアルツハイマー市場：種類別市場規模 2015年-2020年（コリン作動性、メマンチン、併用薬） ・世界のアルツハイマー市場：種類別市場規模予測 2021年-2026年（コリン作動性、メマンチン、併用薬） ・世界のアルツハイマー市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン販売） ・世界のアルツハイマー市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン販売） ・北米のアルツハイマー市場分析：米国、カナダ ・ヨーロッパのアルツハイマー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルツハイマー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルツハイマー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルツハイマー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer’s disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer’s disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer’swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer’s disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer’s disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer’swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Market Analysis and Insights: Global Alzheimer Market
The global Alzheimer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alzheimer Scope and Market Size
Alzheimer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Market segment by Type, the product can be split into
Cholinergic
Memantine
Combined Drug
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Sales
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer Revenue
1.4 Market by Type
1.4.1 Global Alzheimer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cholinergic
1.4.3 Memantine
1.4.4 Combined Drug
1.5 Market by Application
1.5.1 Global Alzheimer Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Sales
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer Market Perspective (2015-2026)
2.2 Global Alzheimer Growth Trends by Regions
2.2.1 Alzheimer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alzheimer Historic Market Share by Regions (2015-2020)
2.2.3 Alzheimer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alzheimer Market Growth Strategy
2.3.6 Primary Interviews with Key Alzheimer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer Players by Market Size
3.1.1 Global Top Alzheimer Players by Revenue (2015-2020)
3.1.2 Global Alzheimer Revenue Market Share by Players (2015-2020)
3.1.3 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer Market Concentration Ratio
3.2.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2019
3.3 Alzheimer Key Players Head office and Area Served
3.4 Key Players Alzheimer Product Solution and Service
3.5 Date of Enter into Alzheimer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alzheimer Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Alzheimer Market Size by Application (2015-2020)
5.2 Global Alzheimer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alzheimer Market Size (2015-2020)
6.2 Alzheimer Key Players in North America (2019-2020)
6.3 North America Alzheimer Market Size by Type (2015-2020)
6.4 North America Alzheimer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Alzheimer Market Size (2015-2020)
7.2 Alzheimer Key Players in Europe (2019-2020)
7.3 Europe Alzheimer Market Size by Type (2015-2020)
7.4 Europe Alzheimer Market Size by Application (2015-2020)
8 China
8.1 China Alzheimer Market Size (2015-2020)
8.2 Alzheimer Key Players in China (2019-2020)
8.3 China Alzheimer Market Size by Type (2015-2020)
8.4 China Alzheimer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Alzheimer Market Size (2015-2020)
9.2 Alzheimer Key Players in Japan (2019-2020)
9.3 Japan Alzheimer Market Size by Type (2015-2020)
9.4 Japan Alzheimer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Alzheimer Market Size (2015-2020)
10.2 Alzheimer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer Market Size by Application (2015-2020)
11 India
11.1 India Alzheimer Market Size (2015-2020)
11.2 Alzheimer Key Players in India (2019-2020)
11.3 India Alzheimer Market Size by Type (2015-2020)
11.4 India Alzheimer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Alzheimer Market Size (2015-2020)
12.2 Alzheimer Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Alzheimer Introduction
13.1.4 Allergan Revenue in Alzheimer Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Alzheimer Introduction
13.2.4 Eisai Revenue in Alzheimer Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Alzheimer Introduction
13.3.4 Novartis Revenue in Alzheimer Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Details
13.4.2 Daiichi Sankyo Business Overview
13.4.3 Daiichi Sankyo Alzheimer Introduction
13.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2015-2020)
13.4.5 Daiichi Sankyo Recent Development
13.5 Merz Pharma
13.5.1 Merz Pharma Company Details
13.5.2 Merz Pharma Business Overview
13.5.3 Merz Pharma Alzheimer Introduction
13.5.4 Merz Pharma Revenue in Alzheimer Business (2015-2020)
13.5.5 Merz Pharma Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Alzheimer Introduction
13.6.4 Pfizer Revenue in Alzheimer Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Alzheimer Introduction
13.7.4 Johnson & Johnson Revenue in Alzheimer Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Lundbeck
13.8.1 Lundbeck Company Details
13.8.2 Lundbeck Business Overview
13.8.3 Lundbeck Alzheimer Introduction
13.8.4 Lundbeck Revenue in Alzheimer Business (2015-2020)
13.8.5 Lundbeck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Alzheimer Key Market Segments
Table 2. Key Players Covered: Ranking by Alzheimer Revenue
Table 3. Ranking of Global Top Alzheimer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alzheimer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cholinergic
Table 6. Key Players of Memantine
Table 7. Key Players of Combined Drug
Table 8. Global Alzheimer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Alzheimer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Alzheimer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Alzheimer Market Share by Regions (2015-2020)
Table 12. Global Alzheimer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Alzheimer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Alzheimer Market Growth Strategy
Table 18. Main Points Interviewed from Key Alzheimer Players
Table 19. Global Alzheimer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Alzheimer Market Share by Players (2015-2020)
Table 21. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2019)
Table 22. Global Alzheimer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Alzheimer Product Solution and Service
Table 25. Date of Enter into Alzheimer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Alzheimer Market Size Share by Type (2015-2020)
Table 29. Global Alzheimer Revenue Market Share by Type (2021-2026)
Table 30. Global Alzheimer Market Size Share by Application (2015-2020)
Table 31. Global Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Alzheimer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Alzheimer Market Share (2019-2020)
Table 35. North America Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Alzheimer Market Share by Type (2015-2020)
Table 37. North America Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Alzheimer Market Share by Application (2015-2020)
Table 39. Europe Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Alzheimer Market Share (2019-2020)
Table 41. Europe Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Alzheimer Market Share by Type (2015-2020)
Table 43. Europe Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Alzheimer Market Share by Application (2015-2020)
Table 45. China Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Alzheimer Market Share (2019-2020)
Table 47. China Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 48. China Alzheimer Market Share by Type (2015-2020)
Table 49. China Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 50. China Alzheimer Market Share by Application (2015-2020)
Table 51. Japan Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Alzheimer Market Share (2019-2020)
Table 53. Japan Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Alzheimer Market Share by Type (2015-2020)
Table 55. Japan Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Alzheimer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Alzheimer Market Share (2019-2020)
Table 59. Southeast Asia Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Alzheimer Market Share by Type (2015-2020)
Table 61. Southeast Asia Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Alzheimer Market Share by Application (2015-2020)
Table 63. India Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Alzheimer Market Share (2019-2020)
Table 65. India Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 66. India Alzheimer Market Share by Type (2015-2020)
Table 67. India Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 68. India Alzheimer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Alzheimer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Alzheimer Market Share (2019-2020)
Table 71. Central & South America Alzheimer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Alzheimer Market Share by Type (2015-2020)
Table 73. Central & South America Alzheimer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Alzheimer Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. Eisai Company Details
Table 81. Eisai Business Overview
Table 82. Eisai Product
Table 83. Eisai Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 84. Eisai Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Daiichi Sankyo Company Details
Table 91. Daiichi Sankyo Business Overview
Table 92. Daiichi Sankyo Product
Table 93. Daiichi Sankyo Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 94. Daiichi Sankyo Recent Development
Table 95. Merz Pharma Company Details
Table 96. Merz Pharma Business Overview
Table 97. Merz Pharma Product
Table 98. Merz Pharma Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 99. Merz Pharma Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Lundbeck Business Overview
Table 111. Lundbeck Product
Table 112. Lundbeck Company Details
Table 113. Lundbeck Revenue in Alzheimer Business (2015-2020) (Million US$)
Table 114. Lundbeck Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Market Share by Type: 2020 VS 2026
Figure 2. Cholinergic Features
Figure 3. Memantine Features
Figure 4. Combined Drug Features
Figure 5. Global Alzheimer Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Sales Case Studies
Figure 9. Alzheimer Report Years Considered
Figure 10. Global Alzheimer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Alzheimer Market Share by Regions: 2020 VS 2026
Figure 12. Global Alzheimer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Alzheimer Market Share by Players in 2019
Figure 15. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2019
Figure 17. North America Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Alzheimer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
アルツハイマー病の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer's Disease Scope and Market Size Alzheimer's Disease market is seg…- アルツハイマー病治療の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer’s Therapeutic Market The global Alzheimer’s Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer’s Therapeutic Scope and Market Size Alzheimer’s Therapeut…
- アルツハイマー病治療法の世界市場（～2026年） Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with e…
- 慢性外傷性脳症（CTE）の世界市場（～2026年） Chronic traumatic encephalopathy (CTE) is a kind of degenerative brain disease that is found in athletes, military veterans, and others with a history of repetitive brain trauma. Market Analysis and Insights: Global Chronic Traumatic Encephalopathy (CTE) Market The global Chronic Traumatic Encephalo…
- ホスピスサービスの世界市場（～2026年） Hospice services are cost-effective humane and compassionate care services provided to the patients who are in the last phase of their life and have completed the medical treatment course for incurable diseases such as congestive heart failure, cancer, dementia and lung disease. These services focus…